Study of DICER1-related tumor history in families
Part of Cancer, Hormones & metabolism clinical trials.
This study follows people affected by DICER1-related tumors (and sometimes family members) to better understand how these conditions develop over time. It may help families by improving knowledge and guiding genetic counseling and future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or your family member) must have a DICER1-related tumor diagnosis that can be confirmed from records or pathology
- You may qualify if you have PPB (pleuropulmonary blastoma) or another tumor linked to DICER1
- You may qualify if you have a known or suspected DICER1 gene change (variant)
- You may qualify as an unaffected family member if you don’t have a known or suspected DICER1 gene change or condition
- There’s no age limit, and prior treatments are allowed
- You (or your guardian) must be able and willing to give informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry collects information about people with known or suspected DICER1-related conditions, including certain rare chest and other tumor types. It helps doctors and researchers understand these conditions better and may support future studies.
This study looks at people and families who have changes in the DDX41 gene or similar genes that may increase the risk of cancer. By joining, you can help researchers learn more about these gene changes and how they affect health.
This study looks at people who have rare or unusual cancers or who may have an inherited (family) risk for cancer. It helps researchers learn what genetic or other factors might be involved by collecting family history and medical records, including pathology slides.
This study looks for genetic causes of immune problems, such as unusually frequent infections, abnormal allergies, or autoimmune or inflammation conditions. It may help by improving how doctors understand these disorders and by matching families with possible genetic diagnoses.
This study collects tumor (or related) samples to analyze their genes and build a shared research “biobank.” It may help researchers understand cancers better for future diagnosis and treatments.
This study follows people (and sometimes family members) connected to rare solid tumors and collects health information and samples (biospecimens). It helps researchers understand how these cancers develop and builds resources for future research, which may benefit you by contributing to better tailored care for rare cancers.
Hear when a new Pleuropulmonary Blastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.